162 related articles for article (PubMed ID: 33982884)
1. Potential role for the tumor suppressor CYLD in brain and notochord development.
Li T; Wang Y; Li D; Zhou J; Zhang B; He X
Thorac Cancer; 2021 Jun; 12(12):1900-1908. PubMed ID: 33982884
[TBL] [Abstract][Full Text] [Related]
2. Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.
La T; Jin L; Liu XY; Song ZH; Farrelly M; Feng YC; Yan XG; Zhang YY; Thorne RF; Zhang XD; Teng L
Oncol Res; 2020 Sep; 28(4):385-398. PubMed ID: 32252875
[TBL] [Abstract][Full Text] [Related]
3. Cylindromatosis Tumor Suppressor Protein (CYLD) Deubiquitinase is Necessary for Proper Ubiquitination and Degradation of the Epidermal Growth Factor Receptor.
Sanchez-Quiles V; Akimov V; Osinalde N; Francavilla C; Puglia M; Barrio-Hernandez I; Kratchmarova I; Olsen JV; Blagoev B
Mol Cell Proteomics; 2017 Aug; 16(8):1433-1446. PubMed ID: 28572092
[TBL] [Abstract][Full Text] [Related]
4. Znrg, a novel gene expressed mainly in the developing notochord of zebrafish.
Zhou Y; Xu Y; Li J; Liu Y; Zhang Z; Deng F
Mol Biol Rep; 2010 Jun; 37(5):2199-205. PubMed ID: 19693699
[TBL] [Abstract][Full Text] [Related]
5. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
6. Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.
Johari T; Maiti TK
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2081-2089. PubMed ID: 29807073
[TBL] [Abstract][Full Text] [Related]
7. Egfl6 is involved in zebrafish notochord development.
Wang X; Wang X; Yuan W; Chai R; Liu D
Fish Physiol Biochem; 2015 Aug; 41(4):961-9. PubMed ID: 25952972
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of CYLD promotes cell survival and inflammation in gefitinib-treated NSCLC PC-9 cells: Targeting CYLD may be beneficial for acquired resistance to gefitinib therapy.
Yuan Y; Liu L; Wang Y; Liu S
Cell Biol Int; 2020 Sep; 44(9):1911-1918. PubMed ID: 32441799
[TBL] [Abstract][Full Text] [Related]
9. [Research progress of deubiquitinating enzyme CYLD to regulate liver-related diseases].
Yang X; An DJ; Gao CC; Qin HY
Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):477-480. PubMed ID: 31357769
[TBL] [Abstract][Full Text] [Related]
10. CYLD deficiency causes auditory neuropathy due to reduced neurite outgrowth.
Yang S; Ma N; Wu X; Ni H; Gao S; Sun L; Zhou P; Tala ; Ran J; Zhou J; Liu M; Li D
J Clin Lab Anal; 2021 Jun; 35(6):e23783. PubMed ID: 33934395
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.
Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V
J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882
[TBL] [Abstract][Full Text] [Related]
12. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
Zhang LM; Zhou JJ; Luo CL
Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
[TBL] [Abstract][Full Text] [Related]
13. Research on mechanism of miR-130a in regulating autophagy of bladder cancer cells through CYLD.
Dai H; Liu C; Liu Y; Zhang Z; Peng C; Wang Z; Zheng J; Li C; Yu W; Cheng F
J BUON; 2020; 25(3):1636-1642. PubMed ID: 32862616
[TBL] [Abstract][Full Text] [Related]
14. Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma.
Miyake S; Miwa T; Yoneda G; Kanemaru A; Saito H; Minoda R; Orita Y; Saito H; Jono H
PLoS One; 2020; 15(10):e0240216. PubMed ID: 33031450
[TBL] [Abstract][Full Text] [Related]
15. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
[TBL] [Abstract][Full Text] [Related]
16. Discovery, characterization and expression of a novel zebrafish gene, znfr, important for notochord formation.
Xu Y; Zou P; Liu Y; Deng F
Mol Biol Rep; 2010 Jun; 37(5):2341-6. PubMed ID: 19688271
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation.
Huang Z; Tan Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176077
[TBL] [Abstract][Full Text] [Related]
18. Premature aging and cancer development in transgenic mice lacking functional CYLD.
Alameda JP; Ramírez Á; García-Fernández RA; Navarro M; Page A; Segovia JC; Sanchez R; Suárez-Cabrera C; Paramio JM; Bravo A; Fernández-Aceñero MJ; Casanova ML
Aging (Albany NY); 2019 Jan; 11(1):127-159. PubMed ID: 30631004
[TBL] [Abstract][Full Text] [Related]
19. CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.
Qi L; Zang H; Wu W; Nagarkatti P; Nagarkatti M; Liu Q; Robbins J; Wang X; Cui T
J Mol Cell Cardiol; 2020 Aug; 145():59-73. PubMed ID: 32553594
[TBL] [Abstract][Full Text] [Related]
20. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]